American Journal of Analytical Chemistry

Volume 6, Issue 2 (January 2015)

ISSN Print: 2156-8251   ISSN Online: 2156-8278

Google-based Impact Factor: 1.71  Citations  h5-index & Ranking

Liquid Chromatography-Tandem Mass Spectrometry Methods for Determination of Delamanid in Mouse Plasma and Lung

HTML  XML Download Download as PDF (Size: 2763KB)  PP. 98-105  
DOI: 10.4236/ajac.2015.62009    4,046 Downloads   5,398 Views  Citations

ABSTRACT

Sensitive and selective liquid chromatography-tandem mass spectrometry methods have been developed and validated for the determination of delamanid in mouse plasma and lung. Sample preparation involved liquid-liquid extraction with diethyl ether for plasma, or protein precipitation followed by liquid-liquid extraction with tert-butyl methyl ether for lung homogenate. Chromatographic separation was performed on a reversed phase column with a linear gradient elution using purified water-formic acid (1000:2, v/v) and methanol-formic acid (1000:2, v/v) at a flow rate of 0.2 mL/min. Detection was performed on a triple-quadrupole tandem mass spectrometer using positive ion electrospray ionization in the selected reaction monitoring mode. The analytical methods were successfully validated for selectivity, calibration curve, accuracy, precision, extraction recovery, and stability over a range of 6 - 1000 ng/mL for plasma and 10 - 1000 ng/mL for lung homogenate. The validated methods were successfully applied for evaluation of pharmacokinetics of delamanid in male mice.

Share and Cite:

Hirao, Y. , Koga, T. , Koyama, N. , Shimokawa, Y. and Umehara, K. (2015) Liquid Chromatography-Tandem Mass Spectrometry Methods for Determination of Delamanid in Mouse Plasma and Lung. American Journal of Analytical Chemistry, 6, 98-105. doi: 10.4236/ajac.2015.62009.

Cited by

[1] Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial
Prats, M Frias, L van der Laan… - Antimicrobial Agents …, 2022
[2] Cumulative fraction of response for once-and twice-daily delamanid in patients with pulmonary multidrug-resistant tuberculosis
2021
[3] Prediction of Human Pharmacokinetic Profiles of the Anti-tuberculosis Drug Delamanid from Nonclinical Data: Potential Therapeutic Value Against Extrapulmonary …
2021
[4] Development and validation of a liquid chromatography-tandem mass spectrometry method for quantifying delamanid and its metabolite in small hair samples
2021
[5] Development and validation of LC–MS/MS method for determination of DNDI-VL-2098 in mouse, rat, dog and hamster blood
2019
[6] Absorption, distribution and excretion of the anti‐tuberculosis drug delamanid in rats: Extensive tissue distribution suggests potential therapeutic value for …
Biopharmaceutics & drug disposition, 2017
[7] Absorption, distribution and excretion of the anti‐tuberculosis drug delamanid in rats: Extensive tissue distribution suggests potential therapeutic value for …
Biopharmaceutics & drug disposition, 2017
[8] Simultaneous quantitation of delamanid (OPC-67683) and its eight metabolites in human plasma using UHPLC–MS/MS
Journal of Chromatography B, 2015

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.